Screener
Krystal Biotech, Inc. KRYS Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except par value) | March 31,2026 | December 31,2025 |
|---|---|---|
| Inventory | 42,646 | 40,475 |
| Prepaid taxes | 10,642 | 14,006 |
| Prepaid expenses and other current assets | 16,026 | 14,905 |
| Total current assets | 1,019,741 | 1,024,602 |
| Property and equipment, net | 153,582 | 150,776 |
| Long-term investments | 193,485 | 128,066 |
| Right-of-use assets | 7,035 | 7,239 |
| Deferred tax asset, net of valuation allowance | 22,824 | 22,824 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s total current assets?
- Krystal Biotech, Inc. (KRYS) reported total current assets of $1.02B in Q1 2026.
- How has Krystal Biotech, Inc.'s total current assets changed year-over-year?
- Krystal Biotech, Inc.'s total current assets increased by 33.0% year-over-year, from $766.8M to $1.02B.
- What is the long-term trend for Krystal Biotech, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s total current assets has grown at a 30.1% compound annual growth rate (CAGR), from $275.06M to $1.02B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Krystal Biotech, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude